Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment — a systematic review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1076
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment — a systematic review ; volume:181 ; number:4 ; day:22 ; month:12 ; year:2021 ; pages:1329-1362 ; date:4.2022
Zeitschrift für Kinderheilkunde ; 181, Heft 4 (22.12.2021), 1329-1362, 4.2022
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00431-021-04283-w
- URN
-
urn:nbn:de:101:1-2022061810101997768786
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Keller, Michèle
- Pittet, Laure
- Zimmermann, Petra
- SpringerLink (Online service)
Ähnliche Objekte (12)
Exploring the relationship between nutritional status and immunogenicity of routine childhood vaccines
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
Immunogenicity of poxvirus-based vaccines against Nipah virus
Improving the immunogenicity of HIV-1 envelope trimer vaccines
Factors affecting the immunogenicity of influenza vaccines in human
Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines
Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Exploring the relationship between nutritional status and immunogenicity of routine childhood vaccines
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
Immunogenicity of poxvirus-based vaccines against Nipah virus
Improving the immunogenicity of HIV-1 envelope trimer vaccines
Factors affecting the immunogenicity of influenza vaccines in human
Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines
Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Exploring the relationship between nutritional status and immunogenicity of routine childhood vaccines
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
Immunogenicity of poxvirus-based vaccines against Nipah virus
Improving the immunogenicity of HIV-1 envelope trimer vaccines
Factors affecting the immunogenicity of influenza vaccines in human
Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines
Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines